The excellence of Europe as a research hub is a result of inclusion and strong networks. Without the researchers from the Swiss and UK’s internationally acclaimed top universities, Europe will weaken its competitive position vis-à-vis the US and Asia.
Dr. René Buholzer, CEO & Delegate of the Board Interpharma